SBIR/STTR Research Award
Fluorescence Microscope For In Vivo Cell Microscopy
Award amount
$244,075Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- OPTICAL BIOPSY TECHNOLOGIES, INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): High-resolution laser scanning microscopes
are widely used in ceIIular biology for the study of fluorescently tagged
molecules in vitro. Sub-micron resolution and fluorescence markers permits the
in vitro study of cells, subcellular organelles, cellular dynamics, cellular
molecules, and proteins derived from the genome. For instance, the GFP (green
fluorescent protein) gene, and other mutant forms of GFP, can be transfected
with viral vectors into the genome, and are activated when a protein is
produced from those genes to which it is specifically fused. The study of that
protein is thus made possible by it being fluorescently tagged with GFP. The
microscopic study of subcellular organelles and cellular processes has
heretofore not been possible in vivo except by gross observation via
fluorescence spectroscopy or by imaging through biological windows embedded in
model mammalian animals. We will develop a novel miniature high-resolution
fluorescence microscope for minimally invasive in vivo microscopy of animal
models. The microscope can be used to image fluorescently tagged molecular
markers in vivo. It will allow the observation of cells, cellular organelles,
and proteins from specifically tagged genes and permit their study in vivo.
Sub-micron resolution is possible from the miniature microscope that has a
millimeter form factor allowing minimally invasive insertion into mammals to
study gene expression. In addition, a large field of view is obtained while
achieving good imaging depths. Molecular markers and gene expression have the
potential to detect early stage cancer.
PROPOSED COMMERCIAL APPLICATION:
Potential applications exist in developmental biology, tumor cell detection, and to accurately
direct pharmacological and mechanical interventions in such diverse fields as cardiology,
pulmonolgy, oncology, and transplantation.
Technology keywords
Not reported